CT KDO_DC1311

by | 20. 7. 2022

CLINICAL TRIAL WHO_DC1311 Combination anti-tumour therapy with ex vivo manipulated interleukin-12 producing dendritic cells in paediatric, adolescent and young adult patients with progressive, relapsed or primary metastatic high-risk malignancies KDO_DC1311 is a phase...

CT HALF

by | 23. 6. 2022

CLINICAL TRIAL HALF Prospective phase II clinical trial evaluating the efficacy and safety of tyrosine kinase inhibitor discontinuation after prior two-step dose reduction in patients with chronic myeloid leukemia in deep molecular remission The HALF clinical trial is...

CT CoVigi

by | 16. 2. 2022

CLINICAL TRIAL CoVigi CoVigi is a phase IV multicentre post-registration intervention study to monitor long-term safety and efficacy after vaccination against COVID-19.The study was initiated by Masaryk University in collaboration with the University Hospital Brno and...

CT REMED

by | 16. 12. 2021

CLINICAL TRIAL REMEDY Effect of dexamethasone in patients with ARDS and COVID-19 – a prospective, multicenter, open-label, randomized controlled trial with parallel groups. COVID-19 is still a major challenge for medical research, with new drugs or possible...

KH SEOTP

by | 29. 1. 2021

SEOTP – Safety and efficacy of olanzapine therapy in psychosis: influence of genetic and epigenetic factors – covariates of treatment response SEOTP is a phase IV clinical trial to improve and innovate existing treatment approaches for psychosis based on...